 Aztreonam treatment gram-negative bacterial meningitis Aztreonam patients presumptive gram-negative bacillary meningitis open multinational study antibiotic dosage adults mg/kg children years old mg/kg infants times Seventy-seven patients gram-negative meningitis due aztreonam-susceptible organism aztreonam hours Haemophilus influenzae pathogen patients Enterobacteriaceae patients Neisseria meningitidis patients Pseudomonas species patients patients Microbiologic failure persistent intracerebral abscess patient foreshortened course therapy microbiologic reevaluation death hours hours hours initiation treatment data aztreonam effective treatment gram-negative bacillary meningitis susceptible organisms